Learn More
Invitrogen™ DCK Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA579140
Description
Reconstitute with 0.2 mL of distilled water to yield a concentration of 500 μg/mL. Positive Control - WB: human Jurkat whole cell, rat thymus tissue, mouse thymus tissue. IHC: human breast cancer tissue, human ovary cancer tissue, human tonsil tissue, mouse liver tissue, rat liver tissue. Flow: U87 cell.
Deoxycytidine kinase (DCK) is required for the phosphorylation of several deoxyribonucleosides and their nucleoside analogs. Deficiency of DCK is associated with resistance to antiviral and anticancer chemotherapeutic agents. Conversely, increased deoxycytidine kinase activity is associated with increased activation of these compounds to cytotoxic nucleoside triphosphate derivatives. DCK is clinically important because of its relationship to drug resistance and sensitivity.
Specifications
DCK | |
Polyclonal | |
Unconjugated | |
DCK | |
DCK; Deoxycytidine kinase; deoxynucleoside kinase | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
13178, 1633, 79127 | |
-20°C | |
Lyophilized |
ELISA, Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot, Western Blot | |
500 μg/mL | |
PBS with 4mg trehalose and no preservative | |
P27707, P43346, P48769 | |
DCK | |
E. coli-derived human DCK recombinant protein (Position: E17-L260). | |
100 μg | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.